SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY
Clinical trials for SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to tame tough head and neck cancers
Disease control OngoingThis study is testing whether combining an immunotherapy drug (cemiplimab) with two low-dose chemotherapy drugs works better for treating head and neck cancer that has returned or spread. It will involve about 46 patients whose cancer has come back or spread and who haven't had o…
Matched conditions: SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY
Phase: PHASE2 • Sponsor: Marcelo Bonomi • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Virus + drug combo tested for Tough-to-Treat skin cancers
Disease control OngoingThis study is testing a two-part treatment for patients with advanced skin cancers or rare lymphomas that have not responded to other therapies. First, a modified virus is injected directly into tumors to help the immune system recognize cancer. Then, an immunotherapy drug is giv…
Matched conditions: SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC